In a recent study, abatacept was administered in children with refractory AIHA following HSCT showing favorable efficacy and safety [49] and indicating that the CTLA4 pathway is likely involved in autoimmunity even without genetic mutations in the corresponding gene. Here, CTLA4 is linked to Autoimmunity.